Details of the Drug | DrugMAP

General Information of Drug (ID: DMMU5CE)

Drug Name

Dialyzable leukocyte cells

Synonyms

Dialyzable leukocyte

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

TTD ID: D01HQJ

References

1	ClinicalTrials.gov (NCT04379479) Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T). U.S. National Institutes of Health.